A model for the quantitative study of central dopaminergic and serotoninergic activity.
D006916:5-Hydroxytryptophan / Q000494:pharmacology; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D002421:Caudate Nucleus / Q000502:physiology; D002746:Chlorpromazine / Q000494:pharmacology; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004298:Dopamine / Q000502:physiology*; D004576:Electromyography; D006220:Haloperidol / Q000494:pharmacology; D007490:Iproniazid / Q000494:pharmacology; D008297:Male; D008781:Methyltyrosines / Q000494:pharmacology; D008784:Methysergide / Q000494:pharmacology; D008954:Models, Biological; D009119:Muscle Contraction / Q000187:drug effects; D009207:Myoclonus / Q000503:physiopathology*; D010276:Parasympatholytics / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D012110:Reserpine / Q000494:pharmacology; D012701:Serotonin / Q000502:physiology*; D013238:Stereotaxic Techniques; D013378:Substantia Nigra / Q000502:physiology; D013788:Thalamus / Q000502:physiology
D008781:Methyltyrosines; D010276:Parasympatholytics; D012701:Serotonin; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D006916:5-Hydroxytryptophan; D007490:Iproniazid; D006220:Haloperidol; D001058:Apomorphine; D002746:Chlorpromazine; D004298:Dopamine; D008784:Methysergide